Lycia Therapeutics

company

About

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$70M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$120M
Lycia Therapeutics has raised a total of $120M in funding over 2 rounds. Their latest funding was raised on Sep 9, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 9, 2021 Series B $70M 1 Detail
Jun 9, 2020 Series A $50M 1 Versant Ventures Detail

Investments

Number of Investments
Number of Lead Investments
34
0
Lycia Therapeutics has made 34 investments. Their most recent investment was on Jul 28, 2021, when Yield Guild Games raised $12.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 28, 2021 Yield Guild Games
Initial Coin Offering $12.50M Blockchain
May 5, 2021 BitPay
Secondary Market Bitcoin
Jan 30, 2021 Aave
Secondary Market Blockchain
Jul 1, 2020 Terra
Secondary Market Blockchain
Aug 30, 2018 Circle
Secondary Market Banking

Investors

Number of Lead Investors
Number of Investors
1
1
Lycia Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series B